mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.4 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.5 |